Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human CaMKII beta ELISA Kit (AC3861)
Cat.#: ASET-2450
Specifications
Description Human CaMKII beta ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human CaMKII beta concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 7.53 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 100-1600 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2231 Human Dystrophin ELISA Kit (AC3642) Quantitative inquiry ASET-1670 Human Histidine Decarboxylase ELISA Kit (AC3081) Quantitative inquiry ASET-2427 Mouse CD147 ELISA Kit (AC3838) Quantitative inquiry ASET-2274 Human ABCA1 ELISA Kit (AC3685) Quantitative inquiry ASET-1538 Rat FOXO1A ELISA Kit (AC2949) Quantitative inquiry ASET-1272 Porcine TIMP1 ELISA Kit (AC2683) Quantitative inquiry ASET-1098 Human COLEC12 ELISA Kit (AC2509) Quantitative inquiry ASET-2271 Human PKC delta ELISA Kit (AC3682) Quantitative inquiry ASET-1572 Human Adenosine A1 Receptor ELISA Kit (AC2983) Quantitative inquiry ASET-1337 Mouse Parkin ELISA Kit (AC2748) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket